|
|
Biography |
|
|
Dr. Yasmine Aguib is the Deputy Director of Life Sciences Research at the Aswan Heart Centre (Magdi Yacoub Foundation, Egypt) and is a scientific consultant to the President of the TU Muenchen (Germany).
In 2001, Dr. Aguib received a scholarship from the German Exchange Service (DAAD) to study Molecular Biotechnology in Germany. She finisher her Bachelor Thesis at the Institute of Biological Chemistry under supervision of Prof. Skerra, a Pioneer in the field of Protein Engineering, where she studied aspects of designing bispecific antibodies for cancer therapy. During her Master studies she was keen on combining specialization with interdisciplinarity and opted for Molecular Medicine, Molecular Biology of infectious diseases and MOT (Management, Organisation & Technology). She then joined Prof. Schaetzl’s research group to start her work the field of neurodegeneration and received the Mayor’s Award for distinguished Research. In 2008 she was awarded the Presidential Science & Engineering Research Fellowship to continue her studies on cellular defense mechanisms and protein degradation. After finishing her PhD she was appointed as a scientific consultant to the university’s president in the fields of life sciences and international strategic alliances.
As a Deputy Director of Molecular Research at the Magdi Yacoub Foundation, Dr. Aguib is responsible for the implementation and execution of AHC Research Strategy that consists of a continuum of population science, translational, and basic science research targeting a large number of complex Cardiovascular Disease conditions in the region.
Under Prof. Yacoub’s guidance and leading a team of young scientists, she is applying interdisciplinary methods of Genomics, Protein- and Cell biology and collaborating with a global Research Network. Her work aims at understanding the role of molecular determinants of Heart disease and disease recovery mechanisms. A special focus is on molecular determinants that distinguishing disease etiology and manifestation in our population. Understanding mechanism of disease and recovery will lead to more powerful disease prevention and prognostic tools and will help optimizing disease treatment for heart disease patients in Egypt and worldwide.
|
|
|
|
|
|
|
Abstract |
|
|
|
|
Understanding molecular determinants of Heart Disease within the Egyptian population |
|
|
|
|
|
|
|
|